Evidence map›Paper›PMID 24295501›Full record

ArticleVirology journal2013

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.

Miguel Lacerda, Penny L Moore, Nobubelo K Ngandu, Michael Seaman, Elin S Gray, Ben Murrell, Mohan Krishnamoorthy, Molati Nonyane, Maphuti Madiga, Constantinos Kurt Wibmer and 12 more

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. HIV broadly neutralizing antibody targets.Current opinion in HIV and AIDS · 2015
    Review
  11. Association between HIV-1 coreceptor usage and resistance to broadly neutralizing antibodies.Journal of acquired immune deficiency syndromes (1999) · 2014
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 4 countries.

Miguel Lacerda
Penny L Moore
Nobubelo K Ngandu
Michael Seaman
Elin S Gray
Ben Murrell
Mohan Krishnamoorthy
Molati Nonyane
Maphuti Madiga
Constantinos Kurt Wibmer
Daniel Sheward
Robert T Bailer
Hongmei Gao
Kelli M Greene
Salim S Abdool Karim
John R Mascola
Bette T M Korber
David C Montefiori
Lynn Morris
Carolyn Williamson
Cathal SeoigheSchool of Mathematics, Statistics and Applied Mathematics, National University of Ireland Galway, Galway, Ireland. cathal.seoighe@nuigalway.ie.
CAVD-NSDP Consortium
National Health Laboratory Service · ZADuke Medical Center · USUniversity of Cape Town · ZANational Institute of Allergy and Infectious Diseases · USOllscoil na Gaillimhe – University of Galway · IEBeth Israel Deaconess Medical Center · USCentre for the AIDS Programme of Research in South Africa · ZALos Alamos National Laboratory · USSanta Fe Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentification of the epitopes targeted by antibodies that can neutralize diverse HIV-1 strains can provide important clues for the design of a preventative vaccine.

methodsWe have developed a computational approach that can identify key amino acids within the HIV-1 envelope glycoprotein that influence sensitivity to broadly cross-neutralizing antibodies. Given a sequence alignment and neutralization titers for a panel of viruses, the method works by fitting a phylogenetic model that allows the amino acid frequencies at each site to depend on neutralization sensitivities. Sites at which viral evolution influences neutralization sensitivity were identified using Bayes factors (BFs) to compare the fit of this model to that of a null model in which sequences evolved independently of antibody sensitivity. Conformational epitopes were identified with a Metropolis algorithm that searched for a cluster of sites with large Bayes factors on the tertiary structure of the viral envelope.

resultsWe applied our method to ID50 neutralization data generated from seven HIV-1 subtype C serum samples with neutralization breadth that had been tested against a multi-clade panel of 225 pseudoviruses for which envelope sequences were also available. For each sample, between two and four sites were identified that were strongly associated with neutralization sensitivity (2ln(BF) > 6), a subset of which were experimentally confirmed using site-directed mutagenesis.

conclusionsOur results provide strong support for the use of evolutionary models applied to cross-sectional viral neutralization data to identify the epitopes of serum antibodies that confer neutralization breadth.

Indexed as

Cross ReactionsAntibodies, NeutralizingComputational Biologyenv Gene Products, Human Immunodeficiency VirusEpitopesHIV-1HIV AntibodiesAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusEpitopesHIV Antibodies

Identifiers

PMID24295501
PMCPMC4220805
OpenAlexW2109102997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.